Crossmark

Plexiform fibrohistiocytic tumor: a clinicopathological and immunohistochemical study of 39 tumors, with evidence for a CSF1-producing “null cell” population

Crossref DOI link: https://doi.org/10.1007/s00428-022-03408-2

Published Online: 2022-09-07

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thangaiah, Judith Jebastin

Dashti, Nooshin K.

Agaimy, Abbas

Fritchie, Karen

Folpe, Andrew L. https://orcid.org/0000-0002-0273-7351
License Information

Text and Data Mining valid from 2022-09-07

Version of Record valid from 2022-09-07
More Information

Article History

Received: 15 July 2022

Revised: 24 August 2022

Accepted: 31 August 2022

First Online: 7 September 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below